Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,076.00
Bid: 12,072.00
Ask: 12,076.00
Change: 48.00 (0.40%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,082.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-British PM Johnson to unveil international travel plan amid COVID-19

Mon, 05th Apr 2021 07:49

* British PM Johnson to set out plans at 1700 local time

* International travel will not start before May 17

* Airlines, hotels hope for a relaunch
(Recasts lead, adds travel quotes)

By Kate Holton

LONDON, April 5 (Reuters) - British Prime Minister Boris
Johnson will unveil a traffic light system to relaunch
international travel on Monday, offering hope for airlines and
European holiday resorts struggling in the COVID-19 pandemic.

Johnson has already announced a staggered plan to ease
coronavirus restrictions in the months ahead. He now wants to
enable international travel to resume without setting back
efforts to curb the spread of COVID-19 in Britain.

At a 5 p.m. (1600 GMT) news conference, he will outline a
system ranking countries as red, amber or green, based on their
levels of infection and vaccination, and on the presence of
coronavirus variants.

Noel Josephides, chairman of travel group Sunvil, said the
industry ideally needed a month to prepare. He hoped any testing
requirements could involve cheaper and rapid tests if customers
were going to be persuaded to book.

"The tour operating and travel agency business cannot go
through another summer of earning nothing. No one's earned
anything for over a year now," he told Reuters.

Britons are among the highest spending tourists in Europe.
Josephides said airlines and hotels were waiting to decide
whether they would resume operations.

British media suggested countries on the green list,
requiring only testing before and after travel, could include
Portugal, Malta, Israel, the United Arab Emirates and the United
States.

Under the plan, international travel would not resume until
May 17 at the earliest. Countries on the amber list would
require self-isolation. Those on the red list would require
quarantine.

Airlines such as easyJet, Ryanair and
British Airways, plus holiday groups such as TUI
, hope to avoid a second lost summer but COVID-19
cases have risen in continental Europe.

Johnson is also widely expected to confirm plans to allow
all retail, outdoor hospitality and hairdressers to open in
England on April 12, with trials of "vaccine passports" taking
place to help relaunch mass events.

The government is offering everyone in England two rapid
tests a week, to break chains of transmission and spot
asymptomatic cases.

"As we continue to make good progress on our vaccine
programme and with our roadmap to cautiously easing restrictions
underway, regular rapid testing is even more important to make
sure those efforts are not wasted," Johnson said in a statement.

Britain has given AstraZeneca and Pfizer
shots to more than half the adult population, and the reopening
of schools in March has so far caused no spike in cases.

(Editing by Jan Harvey, Emelia Sithole-Matarise and Timothy
Heritage)

More News
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.